2m 2m 2m 2m 2m 2m 2m
ADAPTIVE BIOTECH (ADPT)
NASDAQ
$21.00-$0.02 (-0.08%)
Price as of Jul 14, 2026 4:00 AM EDT- $3.4BMarket Cap
- 81.99%1-Year Change
- Diagnostics & ResearchIndustry
ADAPTIVE BIOTECH (ADPT)
$21.00-$0.02 (-0.08%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VIKING GLOBAL INVESTORS LP | 18.74% | 30.0M | 0 (0.00%) | Mar 31, 2026 |
BLACKROCK, INC. | 8.31% | 13.3M | -30,534 (-0.23%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 7.57% | 12.1M | +188,005 (+1.55%) | Dec 31, 2024 |
BLACKROCK INC. | 7.29% | 11.7M | +473,883 (+4.06%) | Jun 30, 2024 |
MATRIX CAPITAL MANAGEMENT COMPANY, LLC | 7.23% | 11.6M | 0 (0.00%) | Dec 31, 2021 |
VANGUARD GROUP INC | 7.05% | 11.3M | +6,983 (+0.06%) | Dec 31, 2025 |
RUBRIC CAPITAL MANAGEMENT LP | 3.91% | 6.3M | -6.9M (-109.66%) | Jun 30, 2025 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 5.36% | 8.6M | +168,852 (+1.97%) | Mar 31, 2026 |
Ark ETF Trust | 1.33% | 2.1M | -25,670 (-1.21%) | Apr 30, 2026 |
FIDELITY SALEM STREET TRUST | 1.13% | 1.8M | +1.7M (+93.71%) | Apr 30, 2026 |
ALGER FUNDS | 1.08% | 1.7M | +47,785 (+2.77%) | Apr 30, 2026 |
AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 1.08% | 1.7M | +530,308 (+30.75%) | Mar 31, 2026 |
LORD ABBETT DEVELOPING GROWTH FUND, INC. | 1.06% | 1.7M | 0 (0.00%) | Apr 30, 2026 |
T. Rowe Price New Horizons Fund, Inc. | 1.03% | 1.6M | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions2.6B (77.20%)
- Mutual Funds635.1M (19.09%)
- Insiders123.3M (3.71%)
- Other0 (0.00%)
Insider Transactions
- 3.71% (123.3M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 8Number of InsiderSelling (last 12 months)
- $680.1MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
LO FRANCIS Chief People Officer | Exempt | Jul 02, 2026 | $0.00 | 12,626 | $0.00 | 59,374 |
ROBINS HARLAN S Chief Scientific Officer | Sell | Jul 02, 2026 | $5.2M | 239,351 | $21.74 | 1.2M |
LO FRANCIS Chief People Officer | Exempt | Jul 02, 2026 | $0.00 | 12,600 | $0.00 | 155,923 |
ROBINS HARLAN S Chief Scientific Officer | Sell | Jul 02, 2026 | $3.3M | 146,889 | $22.45 | 1.0M |
LO FRANCIS Chief People Officer | Exempt | Jul 02, 2026 | $0.00 | 12,637 | $0.00 | 60,222 |
LO FRANCIS Chief People Officer | Exempt | Jul 02, 2026 | $98,482.80 | 12,626 | $7.80 | 250,314 |
LO FRANCIS Chief People Officer | Exempt | Jul 02, 2026 | $152,964.00 | 12,600 | $12.14 | 262,914 |
LO FRANCIS Chief People Officer | Exempt | Jul 02, 2026 | $106,909.02 | 12,637 | $8.46 | 275,551 |
LO FRANCIS Chief People Officer | Sell | Jul 02, 2026 | $1.0M | 44,838 | $22.59 | 230,713 |
LO FRANCIS Chief People Officer | Exempt | Jul 01, 2026 | $27,300.00 | 3,500 | $7.80 | 254,434 |
LO FRANCIS Chief People Officer | Exempt | Jul 01, 2026 | $40,062.00 | 3,300 | $12.14 | 257,734 |
LO FRANCIS Chief People Officer | Exempt | Jul 01, 2026 | $103,262.76 | 12,206 | $8.46 | 269,940 |
LO FRANCIS Chief People Officer | Exempt | Jul 01, 2026 | $18,705.12 | 4,688 | $3.99 | 274,628 |
LO FRANCIS Chief People Officer | Exempt | Jul 01, 2026 | $114,199.68 | 14,064 | $8.12 | 288,692 |
LO FRANCIS Chief People Officer | Sell | Jul 01, 2026 | $193,919.74 | 8,743 | $22.18 | 279,949 |
LO FRANCIS Chief People Officer | Sell | Jul 01, 2026 | $950,872.50 | 42,261 | $22.50 | 237,688 |
LO FRANCIS Chief People Officer | Exempt | Jul 01, 2026 | $0.00 | 3,500 | $0.00 | 72,000 |
LO FRANCIS Chief People Officer | Exempt | Jul 01, 2026 | $0.00 | 3,300 | $0.00 | 168,523 |
LO FRANCIS Chief People Officer | Exempt | Jul 01, 2026 | $0.00 | 12,206 | $0.00 | 72,859 |
LO FRANCIS Chief People Officer | Exempt | Jul 01, 2026 | $0.00 | 4,688 | $0.00 | 81,265 |
LO FRANCIS Chief People Officer | Exempt | Jul 01, 2026 | $0.00 | 14,064 | $0.00 | 126,584 |
BENZENO SHARON Chief Commercial Ofc Imm Med | Exempt | Jun 29, 2026 | $0.00 | 1,837 | $0.00 | 0 |
BENZENO SHARON Chief Commercial Ofc Imm Med | Exempt | Jun 29, 2026 | $0.00 | 24,944 | $0.00 | 37,416 |
BENZENO SHARON Chief Commercial Ofc Imm Med | Exempt | Jun 29, 2026 | $0.00 | 24,944 | $0.00 | 87,303 |
BENZENO SHARON Chief Commercial Ofc Imm Med | Exempt | Jun 29, 2026 | $0.00 | 51,570 | $0.00 | 113,457 |
BENZENO SHARON Chief Commercial Ofc Imm Med | Exempt | Jun 29, 2026 | $22,301.18 | 1,837 | $12.14 | 274,588 |
BENZENO SHARON Chief Commercial Ofc Imm Med | Exempt | Jun 29, 2026 | $211,026.24 | 24,944 | $8.46 | 299,532 |
BENZENO SHARON Chief Commercial Ofc Imm Med | Exempt | Jun 29, 2026 | $99,526.56 | 24,944 | $3.99 | 324,476 |
BENZENO SHARON Chief Commercial Ofc Imm Med | Exempt | Jun 29, 2026 | $418,748.40 | 51,570 | $8.12 | 376,046 |
BENZENO SHARON Chief Commercial Ofc Imm Med | Sell | Jun 29, 2026 | $3.3M | 154,768 | $21.14 | 221,278 |